Effect of Inhaled Albuterol in Pulmonary Hypertension

Summary

The purpose of the present pilot study is to test the hypothesis that in patients with group 1 pulmonary arterial hypertension (PAH) who are on regular oral pulmonary vasodilator therapy, inhaled albuterol causes transient pulmonary vasodilation.

Timeline

Start

2017-10-05

Primary completion

2020-07-02

Completion

2020-07-02

Drugs

Indications